Pro-Dex, Inc. (PDEX)
USD 47.78
(7.69%)
USD 47.78
(7.69%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 7.53 Million USD | -15.43% |
| 2023 | 10.54 Million USD | -14.26% |
| 2022 | 12.3 Million USD | -11.91% |
| 2021 | 13.96 Million USD | 131.51% |
| 2020 | 6.03 Million USD | 53.36% |
| 2019 | 3.93 Million USD | 65466.67% |
| 2018 | 6000.00 USD | -90.16% |
| 2017 | 61 Thousand USD | 32.61% |
| 2016 | 46 Thousand USD | -34.29% |
| 2015 | 70 Thousand USD | 900.0% |
| 2014 | 7000.00 USD | -53.33% |
| 2013 | 15 Thousand USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 774 Thousand USD | -68.54% |
| 2010 | 2.46 Million USD | -15.03% |
| 2009 | 2.89 Million USD | 85.58% |
| 2008 | 1.56 Million USD | -21.57% |
| 2007 | 1.98 Million USD | -12.19% |
| 2006 | 2.26 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 75 Thousand USD | -48.28% |
| 2003 | 145 Thousand USD | -31.28% |
| 2002 | 211 Thousand USD | -15.6% |
| 2001 | 250 Thousand USD | 0.0% |
| 2000 | - USD | -100.0% |
| 1999 | 143 Thousand USD | -97.66% |
| 1998 | 6.12 Million USD | -27.13% |
| 1997 | 8.4 Million USD | 55.56% |
| 1996 | 5.4 Million USD | 1250.0% |
| 1995 | 400 Thousand USD | -20.0% |
| 1994 | 500 Thousand USD | 0.0% |
| 1993 | 500 Thousand USD | 66.67% |
| 1992 | 300 Thousand USD | 0.0% |
| 1991 | 300 Thousand USD | -25.0% |
| 1990 | 400 Thousand USD | -20.0% |
| 1989 | 500 Thousand USD | -16.67% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 7.88 Million USD | -4.18% |
| 2024 Q2 | 9.64 Million USD | -4.01% |
| 2024 Q1 | 10.1 Million USD | -3.8% |
| 2024 Q4 | 7.53 Million USD | -4.41% |
| 2024 FY | 7.53 Million USD | -28.56% |
| 2023 Q4 | 10.54 Million USD | -4.03% |
| 2023 Q3 | 10.99 Million USD | -3.92% |
| 2023 Q2 | 11.44 Million USD | -3.67% |
| 2023 Q1 | 11.87 Million USD | -3.48% |
| 2023 FY | 10.54 Million USD | -14.26% |
| 2022 Q2 | 13.14 Million USD | -3.05% |
| 2022 Q4 | 12.3 Million USD | -3.32% |
| 2022 FY | 12.3 Million USD | -11.91% |
| 2022 Q1 | 13.56 Million USD | -2.91% |
| 2022 Q3 | 12.72 Million USD | -3.2% |
| 2021 Q2 | 10.98 Million USD | 89.09% |
| 2021 Q1 | 5.8 Million USD | -3.71% |
| 2021 FY | 13.96 Million USD | 131.51% |
| 2021 Q4 | 13.96 Million USD | -1.81% |
| 2021 Q3 | 14.22 Million USD | 29.5% |
| 2020 Q1 | 6.79 Million USD | 72.6% |
| 2020 Q2 | 6.55 Million USD | -3.53% |
| 2020 Q3 | 6.3 Million USD | -3.73% |
| 2020 Q4 | 6.03 Million USD | -4.33% |
| 2020 FY | 6.03 Million USD | 53.36% |
| 2019 Q3 | 4.09 Million USD | -3.65% |
| 2019 FY | 3.93 Million USD | 65466.67% |
| 2019 Q4 | 3.93 Million USD | -3.84% |
| 2019 Q2 | 4.24 Million USD | -4.58% |
| 2019 Q1 | 4.45 Million USD | 74066.67% |
| 2018 Q3 | 15 Thousand USD | -51.61% |
| 2018 Q1 | 46 Thousand USD | -24.59% |
| 2018 FY | 6000.00 USD | -90.16% |
| 2018 Q4 | 6000.00 USD | -60.0% |
| 2018 Q2 | 31 Thousand USD | -32.61% |
| 2017 Q4 | 61 Thousand USD | -19.74% |
| 2017 FY | 61 Thousand USD | 32.61% |
| 2017 Q1 | 105 Thousand USD | 128.26% |
| 2017 Q2 | 91 Thousand USD | -13.33% |
| 2017 Q3 | 76 Thousand USD | -16.48% |
| 2016 FY | 46 Thousand USD | -34.29% |
| 2016 Q3 | 52 Thousand USD | -10.34% |
| 2016 Q2 | 58 Thousand USD | -10.77% |
| 2016 Q4 | 46 Thousand USD | -11.54% |
| 2016 Q1 | 65 Thousand USD | -7.14% |
| 2015 Q4 | 70 Thousand USD | -7.89% |
| 2015 FY | 70 Thousand USD | 900.0% |
| 2015 Q1 | 4000.00 USD | -42.86% |
| 2015 Q3 | 76 Thousand USD | 7500.0% |
| 2015 Q2 | 1000.00 USD | -75.0% |
| 2014 Q3 | 9000.00 USD | -25.0% |
| 2014 Q2 | 12 Thousand USD | -14.29% |
| 2014 FY | 7000.00 USD | -53.33% |
| 2014 Q4 | 7000.00 USD | -22.22% |
| 2014 Q1 | 14 Thousand USD | -6.67% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | 15 Thousand USD | -11.76% |
| 2013 FY | 15 Thousand USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q3 | 17 Thousand USD | 0.0% |
| 2012 Q2 | 595 Thousand USD | -13.14% |
| 2012 Q3 | 506 Thousand USD | -14.96% |
| 2012 Q4 | - USD | -100.0% |
| 2012 FY | - USD | -100.0% |
| 2012 Q1 | 685 Thousand USD | -11.5% |
| 2011 Q4 | 774 Thousand USD | -10.31% |
| 2011 Q2 | 836 Thousand USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 FY | 774 Thousand USD | -68.54% |
| 2011 Q3 | 863 Thousand USD | 3.23% |
| 2010 Q3 | 2.56 Million USD | -4.07% |
| 2010 Q2 | 2.67 Million USD | -3.88% |
| 2010 Q1 | 2.78 Million USD | -3.77% |
| 2010 FY | 2.46 Million USD | -15.03% |
| 2010 Q4 | 2.46 Million USD | -4.24% |
| 2009 Q3 | 3 Million USD | -4.12% |
| 2009 Q2 | 3.13 Million USD | 101.67% |
| 2009 Q1 | 1.55 Million USD | -0.45% |
| 2009 FY | 2.89 Million USD | 85.58% |
| 2009 Q4 | 2.89 Million USD | -3.6% |
| 2008 Q2 | 1.84 Million USD | -3.65% |
| 2008 FY | 1.56 Million USD | -21.57% |
| 2008 Q4 | 1.56 Million USD | -12.16% |
| 2008 Q1 | 1.91 Million USD | -3.62% |
| 2008 Q3 | 1.77 Million USD | -3.84% |
| 2007 Q4 | 1.98 Million USD | -3.26% |
| 2007 FY | 1.98 Million USD | -12.19% |
| 2007 Q3 | 2.05 Million USD | -3.29% |
| 2007 Q2 | 2.12 Million USD | -3.19% |
| 2007 Q1 | 2.19 Million USD | -3.05% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | 2.26 Million USD | 0.0% |
| 2006 Q4 | 2.26 Million USD | -2.91% |
| 2006 Q3 | 2.33 Million USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | -100.0% |
| 2005 Q2 | - USD | -100.0% |
| 2005 Q1 | 57 Thousand USD | -24.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 Q1 | 134 Thousand USD | -7.59% |
| 2004 Q2 | 111 Thousand USD | -17.16% |
| 2004 Q3 | 93 Thousand USD | -16.22% |
| 2004 Q4 | 75 Thousand USD | -19.35% |
| 2004 FY | 75 Thousand USD | -48.28% |
| 2003 FY | 145 Thousand USD | -31.28% |
| 2003 Q4 | 145 Thousand USD | -18.08% |
| 2003 Q3 | 177 Thousand USD | -1.12% |
| 2003 Q2 | 179 Thousand USD | -9.14% |
| 2003 Q1 | 197 Thousand USD | -6.64% |
| 2002 Q1 | 230 Thousand USD | -8.0% |
| 2002 Q2 | 242 Thousand USD | 5.22% |
| 2002 Q3 | 395 Thousand USD | 63.22% |
| 2002 Q4 | 211 Thousand USD | -46.58% |
| 2002 FY | 211 Thousand USD | -15.6% |
| 2001 Q2 | - USD | 0.0% |
| 2001 FY | 250 Thousand USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | 250 Thousand USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q2 | 15.85 Thousand USD | -84.15% |
| 2000 Q3 | - USD | -100.0% |
| 2000 Q1 | 100 Thousand USD | -30.07% |
| 2000 FY | - USD | -100.0% |
| 2000 Q4 | - USD | 0.0% |
| 1999 Q4 | 143 Thousand USD | -98.14% |
| 1999 FY | 143 Thousand USD | -97.66% |
| 1999 Q1 | 6.6 Million USD | 7.83% |
| 1999 Q2 | 7.4 Million USD | 12.12% |
| 1999 Q3 | 7.7 Million USD | 4.05% |
| 1998 Q3 | 6.4 Million USD | -1.54% |
| 1998 Q4 | 6.12 Million USD | -4.36% |
| 1998 Q2 | 6.5 Million USD | -13.33% |
| 1998 Q1 | 7.5 Million USD | -10.71% |
| 1998 FY | 6.12 Million USD | -27.13% |
| 1997 Q2 | 7.4 Million USD | 12.12% |
| 1997 Q4 | 8.4 Million USD | -7.69% |
| 1997 Q3 | 9.1 Million USD | 22.97% |
| 1997 FY | 8.4 Million USD | 55.56% |
| 1997 Q1 | 6.6 Million USD | 22.22% |
| 1996 FY | 5.4 Million USD | 1250.0% |
| 1996 Q3 | 5 Million USD | -1.96% |
| 1996 Q1 | 5.8 Million USD | 1350.0% |
| 1996 Q2 | 5.1 Million USD | -12.07% |
| 1996 Q4 | 5.4 Million USD | 8.0% |
| 1995 Q2 | 500 Thousand USD | 0.0% |
| 1995 Q3 | 400 Thousand USD | -20.0% |
| 1995 Q4 | 400 Thousand USD | 0.0% |
| 1995 FY | 400 Thousand USD | -20.0% |
| 1995 Q1 | 500 Thousand USD | 0.0% |
| 1994 Q3 | 200 Thousand USD | 0.0% |
| 1994 Q4 | 500 Thousand USD | 150.0% |
| 1994 Q2 | 200 Thousand USD | -60.0% |
| 1994 FY | 500 Thousand USD | 0.0% |
| 1994 Q1 | 500 Thousand USD | 0.0% |
| 1993 FY | 500 Thousand USD | 66.67% |
| 1993 Q4 | 500 Thousand USD | 66.67% |
| 1993 Q3 | 300 Thousand USD | 0.0% |
| 1993 Q2 | 300 Thousand USD | 0.0% |
| 1993 Q1 | 300 Thousand USD | 0.0% |
| 1992 FY | 300 Thousand USD | 0.0% |
| 1992 Q3 | 300 Thousand USD | 0.0% |
| 1992 Q4 | 300 Thousand USD | 0.0% |
| 1991 Q4 | 300 Thousand USD | 0.0% |
| 1991 FY | 300 Thousand USD | -25.0% |
| 1990 Q4 | 400 Thousand USD | 0.0% |
| 1990 FY | 400 Thousand USD | -20.0% |
| 1989 FY | 500 Thousand USD | -16.67% |
| 1989 Q4 | 500 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 89.986% |
| AngioDynamics, Inc. | 3.93 Million USD | -91.318% |
| AtriCure, Inc. | 60.59 Million USD | 87.563% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | 87.531% |
| BioLife Solutions, Inc. | 18.31 Million USD | 58.844% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 99.701% |
| Daxor Corporation | 755.65 Thousand USD | -897.275% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | -55.96% |
| Femasys Inc. | 4.25 Million USD | -76.977% |
| GlucoTrack, Inc. | 196 Thousand USD | -3744.898% |
| Harvard Bioscience, Inc. | 30.7 Million USD | 75.456% |
| Hologic, Inc. | 2.49 Billion USD | 99.698% |
| ICU Medical, Inc. | 1.57 Billion USD | 99.522% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 109.179% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -106.301% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | 54.668% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 99.135% |
| Microbot Medical Inc. | 40 Thousand USD | -18740.0% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -164011.498% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 99.084% |
| Nephros, Inc. | 1.39 Million USD | -442.158% |
| NovoCure Limited | 596.24 Million USD | 98.736% |
| NEXGEL, Inc. | 513 Thousand USD | -1369.006% |
| NEXGEL, Inc. | 513 Thousand USD | -1369.006% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | 88.84% |
| OraSure Technologies, Inc. | 11.38 Million USD | 33.825% |
| Pulse Biosciences, Inc. | 8.08 Million USD | 6.802% |
| Predictive Oncology Inc. | 2.18 Million USD | -244.27% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -288.861% |
| QuidelOrtho Corporation | 2.27 Billion USD | 99.669% |
| Repligen Corporation | 510.14 Million USD | 98.523% |
| Sanara MedTech Inc. | 9.11 Million USD | 17.306% |
| STAAR Surgical Company | 31.46 Million USD | 76.051% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -2454.576% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.58% |
| Jin Medical International Ltd. | - USD | -Infinity% |